Robert Stratta to Prospective Studies
This is a "connection" page, showing publications Robert Stratta has written about Prospective Studies.
Connection Strength
0.709
-
Khan MA, El-Hennawy H, Jones KC, Harriman D, Farney AC, Rogers J, Orlando G, Stratta RJ. Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard. Clin Transplant. 2018 06; 32(6):e13275.
Score: 0.104
-
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation. Transplant Proc. 2014 Jul-Aug; 46(6):1928-31.
Score: 0.079
-
Singh RP, Farney AC, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant. 2011 Mar-Apr; 25(2):255-64.
Score: 0.063
-
Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009 Sep 27; 88(6):810-9.
Score: 0.057
-
Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Clin Transplant. 2008 Jan-Feb; 22(1):41-9.
Score: 0.051
-
Stratta RJ, Alloway RR, Lo A, Hodge EE. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients. Transplant Proc. 2005 Oct; 37(8):3527-30.
Score: 0.043
-
Stratta RJ, Alloway RR, Lo A, Hodge EE. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years. Transplant Proc. 2005 Oct; 37(8):3531-4.
Score: 0.043
-
Stratta RJ, Alloway RR, Hodge E, Lo A. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. Clin Transplant. 2002 Feb; 16(1):60-8.
Score: 0.034
-
Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Kizilisik AT, Nezakatgoo N, Gaber LW, Gaber AO. A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage. Ann Surg. 2001 Jun; 233(6):740-51.
Score: 0.032
-
Stratta RJ, Gaber AO, Shokouh-Amiri MH, Reddy KS, Egidi MF, Grewal HP, Gaber LW. A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation. Surgery. 2000 Feb; 127(2):217-26.
Score: 0.029
-
Stratta RJ, Taylor RJ, Weide LG, Sindhi R, Sudan D, Castaldo P, Cushing KA, Frisbie K, Radio SJ. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. Transplant Proc. 1996 Apr; 28(2):917-8.
Score: 0.022
-
Stratta RJ, Taylor RJ, Grune MT, Sindhi R, Sudan D, Castaldo P, Cushing KA, Radio SJ, Wisecarver JL, Matamoros A, et al. Experience with protocol biopsies after solitary pancreas transplantation. Transplantation. 1995 Dec 27; 60(12):1431-7.
Score: 0.022
-
Larsen JL, Lynch T, Al'Halawani M, Miller SA, Cushing KA, Baxter BT, Stratta RJ. Carotid intima-media thickness by ultrasound measurement in pancreas transplant candidates. Transplant Proc. 1995 Dec; 27(6):2996.
Score: 0.022
-
Stratta RJ, Taylor RJ, Bynon JS, Lowell JA, Sindhi R, Wahl TO, Knight TF, Weide LG, Duckworth WC. Surgical treatment of diabetes mellitus with pancreas transplantation. Ann Surg. 1994 Dec; 220(6):809-17.
Score: 0.020
-
Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Reed EC, Langnas AN, Pillen TJ, Shaw BW. A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch Surg. 1992 Jan; 127(1):55-63; discussion 63-4.
Score: 0.017
-
Stratta R, Shaefer M, Bradshaw K, Wood R, Langnas A, Zetterman R, Donovan J, Sorrell M, Markin R, Shaw BW. Experience with OKT3 after orthotopic liver transplantation. Transplant Proc. 1991 Jun; 23(3):1970.
Score: 0.016
-
Stratta RJ, Starling JR, D'Alessandro AM, Love RB, Sollinger HW, Kalayoglu M, Belzer FO. Acute colonic ileus (pseudo-obstruction) in renal transplant recipients. Surgery. 1988 Oct; 104(4):616-23.
Score: 0.013
-
Stratta RJ, Armbrust MJ, Oh CS, Pirsch JD, Kalayoglu M, Sollinger HW, Belzer FO. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation. 1988 Feb; 45(2):323-8.
Score: 0.013
-
Rogers J, Stratta RJ, Lo A, Alloway RR. Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients. Transplant Proc. 2005 Oct; 37(8):3552-4.
Score: 0.011
-
Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber LW, Gaber AO. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. Transpl Int. 2001 Dec; 14(6):396-404.
Score: 0.008
-
Morton JJ, Howe SF, Lowell JA, Stratta RJ, Taylor RJ. Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br J Urol. 1995 Apr; 75(4):498-501.
Score: 0.005
-
Shaw BW, Wood RP, Stratta RJ, Pillen TJ, Langnas AN. Stratifying the causes of death in liver transplant recipients. An approach to improving survival. Arch Surg. 1989 Aug; 124(8):895-900.
Score: 0.004